Skip to content

Pirlindole

Drug profile

Also known as: pirlindol, pirlindole HCl, pirlindole hydrochloride, pirlindole mesilate, pirlindole mesylate, pyrazidol, pyrlindole

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Pirlindole is a drug catalogued in DrugCentral. DrugCentral lists 5 molecular targets, including MAOA, TEAD1 and TEAD2. Recorded indications include Depressive disorder.

  • Molecular targets: MAOA, TEAD1, TEAD2 and TEAD4 (5 listed in DrugCentral).
  • Indications: Depressive disorder.
  • Molecular formula: C15H18N2; molecular weight 226.32 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Depressive disorder

Mechanism & targets

Molecular targets (5)

TargetGeneActionActivity
Amine oxidase [flavin-containing] AMAOAinhibitorKi 7.41
Transcriptional enhancer factor TEF-1TEAD1unknownKd 4.92
Transcriptional enhancer factor TEF-4TEAD2unknownIC50 4.48
Transcriptional enhancer factor TEF-3TEAD4unknownIC50 4.44
Transcriptional enhancer factor TEF-5TEAD3unknownIC50 4.36

Chemical structure

Molecular formulaC15H18N2
Molecular weight226.32 g/mol
CAS number60762-57-4
InChIKeyIWVRVEIKCBFZNF-UHFFFAOYSA-N
PubChem CID68802
CC1=CC2=C(C=C1)N1CCNC3CCCC2=C13

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Pirlindole used for?

DrugCentral lists the following indications for Pirlindole: Depressive disorder.

How does Pirlindole work?

Its molecular targets in DrugCentral include MAOA (inhibitor), TEAD1, TEAD2 and TEAD4.

What is the chemical formula of Pirlindole?

Pirlindole has the molecular formula C15H18N2 and a molecular weight of 226.32 g/mol.

Browse: all drugs starting with P · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets5
Indications1
FormulaC15H18N2
DrugCentral ID2206
Interactive profile